<?xml version="1.0" encoding="UTF-8"?>
<ref id="B106-vaccines-07-00074">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barouch</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Tomaka</surname>
    <given-names>F.L.</given-names>
   </name>
   <name>
    <surname>Wegmann</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Stieh</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Alter</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Robb</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Michael</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Peter</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Nkolola</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Borducchi</surname>
    <given-names>E.N.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)</article-title>
  <source>Lancet</source>
  <year>2018</year>
  <volume>392</volume>
  <fpage>232</fpage>
  <lpage>243</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31364-3</pub-id>
  <pub-id pub-id-type="pmid">30047376</pub-id>
 </element-citation>
</ref>
